–
Sagimet Biosciences Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.7
FY22:
−31.1
FY23:
−30.7
FY24:
−54.5
FY25:
−56.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−31.1
FY23:
−30.7
FY24:
−54.5
FY25:
−56.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.4
FY22:
−30.5
FY23:
−27.9
FY24:
−45.6
FY25:
−51.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.4
FY22:
−30.5
FY23:
−27.9
FY24:
−45.6
FY25:
−51.0
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.